ABCB1 and neoplasm: However, its application to brain tumours is somewhat controversial due to concerns about its ability to permeate the blood-brain barrier (BBB), rapid clearance from the tumour bed and is a substrate of P-glycoprotein, the BBB’s drug efflux transporter [66,67,68,69,70].